TRIMEGAVOG FORTE 2MG (Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg))

Trimegavog 2 Tablet SR is classified as an anti-diabetic medication, utilized for managing type 2 diabetes mellitus in adults. This treatment combines several pharmacological agents to assist individuals in regulating their blood sugar levels effectively. It is recommended to take Trimegavog 2 Tablet SR in conjunction with or just prior to meals to maximize its effectiveness. Adhering to a consistent schedule each day is crucial for optimal outcomes. Your healthcare provider will determine the most appropriate dosage for you, which may be adjusted periodically based on your blood glucose readings and overall response to the treatment. Continuation of this medication is important even if you feel well or your blood sugar levels appear stable. Discontinuing the treatment without consulting your physician could result in an increase in blood sugar, heightening the risk of significant complications, including renal impairment, vision loss, nerve damage, and the potential for amputations. It is essential to recognize that this medication should be part of a comprehensive management plan that includes a balanced diet, regular physical activity, and weight management as outlined by your healthcare professional. Lifestyle modifications are pivotal in diabetes management. Patients should also be aware of potential symptoms of hypoglycemia, such as sweating, dizziness, headaches, and tremors, and learn how to address these situations appropriately. Regular meal intake and carrying quick sources of glucose, like sweets or fruit juice, are recommended for prevention. While taking Trimegavog 2 Tablet SR, one should be cautious of alcohol consumption, as it can elevate the risk of low blood sugar levels. Other possible side effects may include appetite loss, gastrointestinal discomfort, changes in taste, headaches, edema, blurred vision, increased likelihood of bone fractures, and upper respiratory infections. Weight gain may also occur during treatment. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Prior to starting this medication, it’s important to inform your doctor about any pre-existing heart conditions, as this could influence the treatment suitability. Regular monitoring of blood sugar levels and routine blood tests may be necessary for assessing blood cell counts and liver function.